Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
As of July 16, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年7月16日，醫療保健板塊的三隻股票可能對那些將動量視爲交易決策關鍵標準的投資者發出真正的警告。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI是一種動量指標，它將股票在股價上升的日子裏的強度與在股價下跌的日子裏的強度進行比較。與股票價格的走勢相比，它可以讓交易員更好地了解股票在短期內的表現。當RSI高於70時，資產通常被認爲是超買的，據Benzinga Pro稱。
Here's the latest list of major overbought players in this sector.
以下是行業中超買的主要股票列表。
Aveanna Healthcare Holdings Inc (NASDAQ:AVAH)
Aveanna Healthcare Holdings Inc（納斯達克:AVAH）
- On May 9, Aveanna Healthcare posted a narrower-than-expected quarterly loss. Jeff Shaner, Chief Executive Officer, commented, "Our first quarter results reflect the continued positive momentum at Aveanna, highlighted by revenue and Adjusted EBITDA growth of 5.2% and 22.5% respectively, when compared to the prior year period." The company's stock gained around 38% over the past five days and has a 52-week high of $3.66.
- RSI Value: 76.61
- AVAH Price Action: Shares of Aveanna Healthcare gained 10.3% to close at $3.52 on Monday.
- 5月9日，Aveanna Healthcare發佈了一份比預期虧損小的季度業績。首席執行官Jeff Shaner評論道：“我們的第一季度業績反映了Aveanna的持續積極勢頭，與去年同期相比，營業收入和調整後的EBITDA分別增長了5.2%和22.5%。”該公司的股票在過去五個交易日內上漲了約38%，52周高點爲3.66美元。
- RSI價值: 76.61
- AVAH價格走勢：Aveanna Healthcare的股價於週一收盤上漲10.3%，報3.52美元。
Revolution Medicines Inc (NASDAQ:RVMD)
revolution medicines公司 （納斯達克:RVMD）
- On July 12, Barclays analyst Peter Lawson initiated coverage on Revolution Medicines with an Overweight rating and announced a price target of $52. The company's stock gained around 24% over the past month and has a 52-week high of $48.61.
- RSI Value: 75.60
- RVMD Price Action: Shares of Revolution Medicines gained 1.9% to close at $46.00 on Monday.
- 7月12日，巴克萊分析師彼得·勞森（Peter Lawson）開始爲革命醫藥公司進行覆蓋，評級爲“增持”並公佈了52美元的目標價。該公司的股票在過去一個月內上漲了約24%，52周高點爲48.61美元。
- RSI價值: 75.60
- RVMD價格走勢：革命醫藥公司的股價於週一上漲了1.9%，報46.00美元。
Fulcrum Therapeutics Inc (NASDAQ:FULC)
fulcrum therapeutics公司 （納斯達克:FULC）
- On July 10, Cantor Fitzgerald analyst Kristen Kluska reiterated Fulcrum Therapeutics with an Overweight and maintained a $23 price target. The company's stock gained around 40% over the past five days and has a 52-week high of $13.70.
- RSI Value: 70.72
- FULC Price Action: Shares of Fulcrum Therapeutics gained 5.5% to close at $8.45 on Monday.
- 7月10日，康泰菲分析師克里斯汀·克魯斯卡（Kristen Kluska）重申了對Fulcrum Therapeutics的“增持”評級，並維持了23美元的價格目標。該公司的股票在過去五個交易日內上漲了約40%，52周高點爲13.70美元。
- RSI價值: 70.72
- FULC價格走勢：Fulcrum Therapeutics的股價於週一上漲了5.5%，收於8.45美元。
- Bank Of America, Morgan Stanley And Other 3 Stocks To Watch Heading Into Tuesday
- 美國銀行、大摩資源lof和其他3只股票將在週二受到關注